V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310002899 | 310001240 | 1.56 | 74 | Curative (C) | null | 2018-01-24 | Cisplatin | N | Y | 310016551 | CISPLATIN |
| 310002900 | 310001241 | null | null | Palliative (P) | 2016-02-14 | 2016-02-18 | Ipilimumab | 2 | N | 310016553 | IPILIMUMAB |
| 310002901 | 310001241 | 1.73 | 71 | Palliative (P) | 2017-06-05 | 2017-06-24 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 310016553 | CISPLATIN + GEMCITABINE |
| 310002902 | 310008967 | 1.65 | null | Not known (9) | 2016-02-14 | 2016-02-23 | DOXORUBICIN | 02 | N | 310016557 | DOXORUBICIN |
| 310002903 | 310008967 | 1.63 | 5.5 | Adjuvant (A) | 2014-07-28 | 2014-07-29 | Cisplatin | 02 | Y | 310016557 | CISPLATIN |
| 310002904 | 310008967 | null | 83.4 | Palliative (P) | 2018-02-17 | 2018-02-27 | PEMBROLIZUMAB | N | N | 310016557 | PEMBROLIZUMAB |
| 310002905 | 310001242 | 1.66 | 53.9 | Palliative (P) | 2017-06-10 | 2017-06-24 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016568 | CISPLATIN + GEMCITABINE |
| 310002906 | 310006480 | 1.85 | 61.4 | Palliative (P) | 2016-05-05 | 2016-06-01 | CISPLATIN + GEMCITABINE | N | null | 310016569 | CISPLATIN + GEMCITABINE |
| 310002909 | 310001244 | 1.74 | 101.25 | Palliative (P) | 2015-12-11 | 2015-12-12 | PEMBROLIZUMAB | N | N | 310016590 | PEMBROLIZUMAB |
| 310002910 | 310001244 | null | 83.4 | null | 2015-05-18 | 2015-05-24 | Cisplatin+Gemcitabine (Days 1&8&15) | 02 | N | 310016590 | CISPLATIN + GEMCITABINE |
| 310002911 | 310008968 | 1.6 | 141 | Neo-adjuvant (N) | 2018-04-29 | 2018-04-29 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310016597 | CISPLATIN + GEMCITABINE |
| 310002912 | 310001245 | 1.6 | 4 | Palliative (P) | 2016-08-08 | 2016-08-08 | CISPLATIN + GEMCITABINE | N | N | 310016601 | CISPLATIN + GEMCITABINE |
| 310002913 | 310001245 | 1.62 | 66.3 | Adjuvant (A) | 2015-09-29 | 2015-10-05 | Cisplatin+Gemcitabine (Days 1&8&15) | 01 | N | 310016601 | CISPLATIN + GEMCITABINE |
| 310002914 | 310001246 | 1.9 | 71.15 | Palliative (P) | 2014-04-08 | 2014-04-18 | DOXORUBICIN | 02 | N | 310016608 | DOXORUBICIN |
| 310002918 | 310001248 | null | 140 | Palliative (P) | null | 2015-03-01 | CISPLATIN + GEMCITABINE | null | null | 310016624 | CISPLATIN + GEMCITABINE |
| 310002919 | 310001248 | 1.7 | 64 | null | 2014-11-22 | 2014-11-22 | CARBOPLATIN + ETOPOSIDE | N | N | 310016624 | CARBOPLATIN + ETOPOSIDE |
| 310002920 | 310001248 | null | null | Curative (C) | 2016-10-10 | 2016-10-11 | CHEMO-T TRIAL | 01 | N | 310016624 | TRIAL |
| 310002921 | 310001248 | null | 89.8 | Palliative (P) | 2017-09-18 | 2017-10-15 | Ipilimumab | 2 | null | 310016624 | IPILIMUMAB |
| 310002922 | 310001248 | 1.87 | 63 | Palliative (P) | 2016-05-02 | 2016-05-02 | DOXORUBICIN | 2 | N | 310016624 | DOXORUBICIN |
| 310002923 | 310001249 | 0 | null | Curative (C) | 2016-10-27 | 2016-11-01 | Retinoblastoma JOE | N | N | 310016638 | CEV |
| 310002924 | 310001250 | 1.57 | 8.6 | Curative (C) | 2013-07-27 | 2013-07-27 | CHOP R - 21 days | 02 | N | 310016639 | CHOP R |
| 310002925 | 310006486 | null | 76 | Curative (C) | 2015-12-23 | 2016-01-04 | Retinoblastoma JOE | N | N | 310016642 | CEV |
| 310002926 | 310001251 | 1.9 | 90.3 | Palliative (P) | 2015-10-25 | 2015-10-25 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310016650 | CISPLATIN + GEMCITABINE |
| 310002927 | 310001251 | 1.52 | 54.6 | Palliative (P) | 2016-01-27 | 2016-01-27 | PEMBROLIZUMAB | 2 | N | 310016650 | PEMBROLIZUMAB |
| 310002928 | 310001252 | 1.83 | 80 | Palliative (P) | 2014-01-26 | 2014-02-13 | PEMBROLIZUMAB | N | N | 310016656 | PEMBROLIZUMAB |
| 310002929 | 310001252 | null | 72.1 | Curative (C) | 2017-04-03 | 2017-04-03 | Trial Unspecified | Y | N | 310016656 | TRIAL |
| 310002930 | 310001252 | 1.83 | 14.6 | Palliative (P) | 2017-08-09 | 2017-08-15 | PEMBROLIZUMAB | 02 | N | 310016656 | PEMBROLIZUMAB |
| 310002931 | 310001252 | 1.6 | 74 | Palliative (P) | 2015-12-23 | 2016-01-23 | Cisplatin 7 day | 02 | Y | 310016656 | CISPLATIN |
| 310002932 | 310001253 | 1.74 | 97 | Palliative (P) | 2017-10-14 | 2017-10-14 | CISPLATIN + GEMCITABINE | 02 | N | 310016669 | CISPLATIN + GEMCITABINE |
| 310002933 | 310001254 | 1.91 | null | Palliative (P) | 2015-04-28 | 2015-05-11 | Doxorubicin 75mg/m2 | N | N | 310016671 | DOXORUBICIN |
| 310002934 | 310006489 | 1.85 | null | Disease modification (D) | 2015-03-25 | 2015-03-25 | CHOP R - 21 days | 02 | N | 310016672 | CHOP R |
| 310002935 | 310006489 | 1.75 | 77 | Curative (C) | 2015-04-19 | 2015-04-22 | Cisplatin 7 day | N | Y | 310016672 | CISPLATIN |
| 310002936 | 310001255 | 1.55 | 78 | Palliative (P) | 2016-11-26 | 2016-11-26 | TOUCAN TRIAL | Y | N | 310016674 | TRIAL |
| 310002937 | 310001255 | 1.75 | 88 | Palliative (P) | 2018-02-03 | 2018-02-07 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016674 | CISPLATIN + GEMCITABINE |
| 310002938 | 310001255 | 1.71 | 94 | Palliative (P) | 2013-11-12 | 2013-11-12 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 310016674 | CISPLATIN + GEMCITABINE |
| 310002939 | 310001256 | 1.52 | 91.6 | Curative (C) | 2014-07-25 | 2014-07-25 | CHOP R | N | N | 310016679 | CHOP R |
| 310002940 | 310001256 | 1.7 | 69.3 | Neo-adjuvant (N) | 2014-04-10 | 2014-04-11 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016679 | CISPLATIN + GEMCITABINE |
| 310002941 | 310001257 | 1.75 | 60.3 | Curative (C) | 2014-07-02 | 2014-09-14 | CHOP R - 21 days | N | N | 310016693 | CHOP R |
| 310002942 | 310001258 | 1.6 | 56.8 | Curative (C) | 2017-07-10 | 2017-07-28 | Carboplatin + Etoposide iv&po | 02 | N | 310016694 | CARBOPLATIN + ETOPOSIDE |
| 310002943 | 310001258 | null | 76.7 | null | 2017-07-23 | 2017-08-03 | CISPLATIN + GEMCITABINE | 02 | N | 310016694 | CISPLATIN + GEMCITABINE |
| 310002944 | 310001259 | 1.57 | 77.4 | Palliative (P) | 2017-06-25 | 2017-07-03 | CARBOPLATIN + ETOPOSIDE | N | N | 310016705 | CARBOPLATIN + ETOPOSIDE |
| 310002945 | 310001260 | 1.64 | 71.15 | Neo-adjuvant (N) | 2016-11-07 | 2016-11-12 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310016713 | CISPLATIN + GEMCITABINE |
| 310002946 | 310006493 | 1.88 | 99.4 | Palliative (P) | 2015-12-17 | 2015-12-21 | Carboplatin + Etoposide iv&po | N | N | 310016722 | CARBOPLATIN + ETOPOSIDE |
| 310002947 | 310001261 | 1.63 | 59.7 | Palliative (P) | 2014-10-18 | 2014-10-18 | Doxorubicin 75mg/m2 | 02 | N | 310016729 | DOXORUBICIN |
| 310002948 | 310001261 | 1.63 | 95.7 | Palliative (P) | 2017-04-05 | 2017-04-08 | PEMBROLIZUMAB | N | N | 310016729 | PEMBROLIZUMAB |
| 310002949 | 310001262 | 1.6 | 41 | Curative (C) | 2017-06-03 | 2017-06-03 | Trial Unspecified | 01 | N | 310016733 | TRIAL |
| 310002950 | 310001262 | 1.71 | 84.4 | Palliative (P) | 2013-08-02 | 2013-08-16 | CISPLATIN + GEMCITABINE | null | N | 310016733 | CISPLATIN + GEMCITABINE |
| 310002951 | 310001262 | null | 24.9 | Palliative (P) | 2013-11-22 | 2013-11-30 | Ipilimumab | 2 | N | 310016733 | IPILIMUMAB |
| 310002952 | 310001262 | 1.68 | 108 | Adjuvant (A) | 2017-08-18 | 2017-08-18 | Cisplatin+Gemcitabine (gallbladder) | Y | N | 310016733 | CISPLATIN + GEMCITABINE |
| 310002953 | 310001262 | null | 9.5 | Palliative (P) | 2018-09-02 | 2018-09-18 | Ipilimumab | N | N | 310016733 | IPILIMUMAB |